UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1‐3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.169_2631
Abstract: with eBPP at 4 UK centres. Results: From 2009, 103 patients were managed first line with either eBPP (n=51) or eBPDac (n=52) with median follow-up 37 months for eBPP and 10.4 months for eBPDac patients.… read more here.
Keywords: ebpdac patients; ebpp patients; efficacy; patients achieved ... See more keywords
Differences between patients who achieved asthma control and those who remain uncontrolled after standardized severe asthma care strategy
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Asthma"
DOI: 10.1080/02770903.2020.1852415
Abstract: Abstract Objective To assess clinical, functional, and inflammatory patterns of children and adolescents with severe uncontrolled asthma, and investigate the differences between patients who achieved asthma control and those who remain uncontrolled after standardized asthma… read more here.
Keywords: asthma control; patients achieved; achieved asthma; severe uncontrolled ... See more keywords
Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy
Sign Up to like & getrecommendations! Published in 2017 at "Japanese Journal of Clinical Oncology"
DOI: 10.1093/jjco/hyx120
Abstract: Background The whole brain radiotherapy (WBRT) dose for primary central nervous system lymphoma (PCNSL) patients who achieved complete response after induction chemotherapy was recently reduced to 23.4 Gy, but the optimal radiation dose for patients… read more here.
Keywords: response; central nervous; patients achieved; primary central ... See more keywords
Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-214868
Abstract: Objectives Sustained disease-modifying antirheumatic drug (DMARD)-free status, the sustained absence of synovitis after cessation of DMARD therapy, is infrequent in autoantibody-positive rheumatoid arthritis (RA), but approximates cure (ie, disappearance of signs and symptoms). It was… read more here.
Keywords: free status; immunological remission; dmard free; remission ... See more keywords